Obagi Medical Products, Inc. (NASDAQ:OMPI)
CAPS Rating:
A pharmaceutical company focused on the aesthetic and skin health markets. The Company develops and commercializes prescription-based, topical skin health systems.
A pharmaceutical company focused on the aesthetic and skin health markets. The Company develops and commercializes prescription-based, topical skin health systems.
Recs
Just bought some, so I thought I should list it here. I believe this is a very attactive price point for a company that should recover well when the economy improves.